ESSA Pharma Inc.
EPIX · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $91 | $118 | $122 | $109 |
| Gross Profit | -$91 | -$118 | -$122 | -$109 |
| % Margin | – | – | – | – |
| R&D Expenses | $21,207 | $21,323 | $24,415 | $24,259 |
| G&A Expenses | $13,080 | $10,789 | $12,545 | $12,775 |
| SG&A Expenses | $13,214 | $10,812 | $12,545 | $12,775 |
| Sales & Mktg Exp. | $134 | $23 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $109 |
| Operating Expenses | $34,421 | $32,134 | $36,960 | $37,144 |
| Operating Income | -$34,421 | -$32,134 | -$35,343 | -$36,909 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $5,878 | $5,553 | $1,745 | $304 |
| Pre-Tax Income | -$28,543 | -$26,581 | -$35,215 | -$36,840 |
| Tax Expense | $0 | $2 | -$112 | -$34 |
| Net Income | -$28,543 | -$26,582 | -$35,103 | -$36,805 |
| % Margin | – | – | – | – |
| EPS | -0.64 | -0.6 | -0.8 | -0.96 |
| % Growth | -6.7% | 25% | 16.7% | – |
| EPS Diluted | -0.64 | -0.6 | -0.8 | -0.96 |
| Weighted Avg Shares Out | 44,277 | 44,090 | 44,038 | 38,480 |
| Weighted Avg Shares Out Dil | 44,277 | 44,090 | 44,038 | 38,480 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5,875 | $5,554 | $1,737 | $235 |
| Interest Expense | $0 | $7 | $14 | $22 |
| Depreciation & Amortization | $91 | $118 | $122 | $109 |
| EBITDA | -$28,452 | -$26,455 | -$35,080 | -$36,708 |
| % Margin | – | – | – | – |